Cannabis use during the early COVID-19 pandemic: Use patterns, predictors, and subjective experiences

• Juliane Mielau,
• Simon Reiche,
• Daa Un Moon,
• Elisa Groß,
• Stefan Gutwinski,
• Stefan Gutwinski,
• Felix Betzler,
• Amy Romanello,
• Amy Romanello,
• Dario Jalilzadeh Masah,
• Matteo Scicchitano,
• Roman Marek,
• Roman Marek,
• Roman Marek,
• Lasse Brandt,
• Ricarda Evens,
• Ricarda Evens,
• Inge Maria Mick,
• Inge Maria Mick,
• Tomislav Majić,
• Tomislav Majić,
• Christiane Montag

Affiliations

Juliane Mielau

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Simon Reiche

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Daa Un Moon

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Elisa Groß

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Stefan Gutwinski

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Stefan Gutwinski

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Felix Betzler

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Amy Romanello

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Amy Romanello

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Dario Jalilzadeh Masah

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Matteo Scicchitano

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Roman Marek

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Roman Marek

Interdisciplinary Research Group “The Future of Medicine: Good Health for All,” Berlin-Brandenburg Academy of Sciences and Humanities, Berlin, Germany

Roman Marek

German Sepsis Foundation, Berlin, Germany

Lasse Brandt

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Ricarda Evens

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Ricarda Evens

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Inge Maria Mick

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Inge Maria Mick

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Tomislav Majić

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Tomislav Majić

Research Group Psychotropic Substances, Charité Campus Mitte, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Psychiatric University Clinic at Hospital St. Hedwig, Berlin, Germany

Christiane Montag

Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany